Home/Filings/4/0001209191-18-045340
4//SEC Filing

KENYON LAWRENCE A 4

Accession 0001209191-18-045340

CIK 0001649989other

Filed

Aug 2, 8:00 PM ET

Accepted

Aug 3, 5:09 PM ET

Size

5.7 KB

Accession

0001209191-18-045340

Insider Transaction Report

Form 4
Period: 2018-08-01
KENYON LAWRENCE A
CFO and Secretary
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-08-01+500,000500,000 total
    Exercise: $0.86Exp: 2028-08-01Common Stock (500,000 underlying)
Footnotes (1)
  • [F1]The shares underlying the option shall vest in four equal installments beginning on August 1, 2019 such that the option shall be vested in full on August 1, 2022, subject to the Reporting Person providing continuous service to the Issuer on each such date. Vesting may be accelerated in the event of (a) a change in control as defined in the Issuer's 2015 Equity Incentive Plan and (b) the achievement of certain pre-defined corporate objectives, in each case subject to the Reporting Person providing continuous service to the Issuer through such event.

Issuer

Oncobiologics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001230484

Filing Metadata

Form type
4
Filed
Aug 2, 8:00 PM ET
Accepted
Aug 3, 5:09 PM ET
Size
5.7 KB